🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

US STOCKS-S&P 500 aims for record open on IBM support, fading China virus fears

Published 01/22/2020, 09:00 PM
Updated 01/22/2020, 09:08 PM
© Reuters.  US STOCKS-S&P 500 aims for record open on IBM support, fading China virus fears
AMAT
-
ASML
-
MU
-
AMD
-
NFLX
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Futures up: Dow 0.31%, S&P 0.43%, Nasdaq 0.76%

By Sruthi Shankar
Jan 22 (Reuters) - U.S. stock index futures pointed to fresh
highs for the S&P 500 on Wednesday, as investors took heart from
China's efforts to contain a deadly virus outbreak, while strong
results from IBM and Netflix boosted earnings optimism.
Wall Street's main indexes slipped from record highs on
Tuesday after officials confirmed the first U.S. case of the
coronavirus that has killed nine and infected 440 in China.
The outbreak, which revived fears of a pandemic similar to
the Severe Acute Respiratory Syndrome (SARS) in 2003, roiled
travel and airline stocks on Tuesday, as millions of people
prepared to travel for the Chinese Lunar New Year.
A batch of strong earnings reports helped lift sentiment.
International Business Machines Corp IBM.N rose 4.4% in
premarket trading after forecasting full-year profit above
market expectations on strength in its high-margin cloud
computing business. Netflix Inc NFLX.O rose 1.9% as international growth
helped the streaming video service beat expectations for
subscription growth, even as it warned of a tough first quarter.
U.S. semiconductor stocks benefited from a strong forecast
from Dutch firm ASML Holding NV ASML.AS , the latest large
chipmaker to indicate a recovery in the sector. Chip-gear maker Applied Materials Inc AMAT.O rose 1.9%,
while Micron Technology Inc MU.O and Advanced Micro Devices
Inc AMD.O gained about 1% each.
Among the weak spots was Johnson & Johnson JNJ.N , dropping
1.6% after missing quarterly revenue estimates due to
disappointing sales of its blockbuster psoriasis medicine
Stelara and cancer drug Imbruvica. With markets looking to regain momentum following a wobbly
session on Tuesday, investors kept a close watch on developments
around U.S. President Donald Trump's impeachment trial and the
annual meeting of world leaders and business heads in
Davos. At 7:30 a.m. ET, Dow e-minis 1YMcv1 were up 90 points, or
0.31%. S&P 500 e-minis EScv1 were up 14.25 points, or 0.43%
and Nasdaq 100 e-minis NQcv1 were up 70 points, or 0.76%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.